Allstocks.com's Bulletin Board Post A Reply
my profile login | register | search | faq | forum home

» Allstocks.com's Bulletin Board » Pink Sheet Stocks » XYTS » Post A Reply

Post A Reply
Login Name:
Password:
Message Icon: Icon 1     Icon 2     Icon 3     Icon 4     Icon 5     Icon 6     Icon 7    
Icon 8     Icon 9     Icon 10     Icon 11     Icon 12     Icon 13     Icon 14    
Message:

HTML is not enabled.
UBB Code™ is enabled.
UBB Code™ Images not permitted.

 

Instant Graemlins Instant UBB Code™
Smile   Frown   Embarrassed   Big Grin   Wink   Razz  
Cool   Roll Eyes   Mad   Eek!   Confused   BadOne  
Good Luck   More Crap   Wall Bang   Were Up   Were Down    
Insert URL Hyperlink - UBB Code™   Insert Email Address - UBB Code™
Bold - UBB Code™   Italics - UBB Code™
Quote - UBB Code™   Code Tag - UBB Code™
List Start - UBB Code™   List Item - UBB Code™
List End - UBB Code™  

What is UBB Code™?
Options


Disable Graemlins in this post.


 


T O P I C     R E V I E W
luckylindy  - posted
XYTS News: Press Release Source: XYTOS, Inc. On Thursday January 27, 2011, 8:30 am

CARSON CITY, Nev.--(BUSINESS WIRE)-- XYTOS (the "Company") (OTC:XYTS.ob - News) Shares Patient Results.


Tim Cook, Chairman and CEO of XYTOS, Inc., commented, “We offer a sampling of our patient results in an effort to educate readers on the benefits of the XYTOS Treatment. It is important to understand that the XYTOS treatment is not a substitute for surgery in breast cancer patients and although it can be beneficial to many patients, the treatment will not help all cancer patients. The XYTOS treatment focuses on metastasis, not large tumors with limited blood supply. The XYTOS treatment is an alternative to Chemotherapy, Radiation and Hormone therapy, without the side effects associated with these conventional treatments. Note that our patient results are to extensive to post here but additional results for Breast, Skin and Prostate Cancer Patients are available for review on the XYTOS website at www.xytos.com”


Prostate Cancer Results -- Six Patients:


Patient #1 -- 53y. Grade II. Biopsy positive, 3-4 urinations/night Result after XYTOS Therapy – Clear / All symptoms gone. Patient #2 -- 65y. Grade II with local invasion -- Clear, feeling the best he has for years. Patient #3 -- 42y. Grade IV. Very poor health, almost moribund. PSA 9000 -- Died. PSA had dropped to 5000. In retrospect, should not have treated patient. Patient #4 -- 78y. Grade IV, metastases outside the gland. Nocturia, poor urine flow and volume. Impotent. Result -- Prostate shrunk, softened. All symptoms gone. Urinary frequency and volume normal. Still some abnormal test values. Patient #5 --- 41y. Grade IV, huge prostate. Much difficulty urinating and defecating. Now potent erection and ejaculation. Prostate very hard – Result -- Improved urination. Shrinkage. Treatment is working. Patient #6 Grade III. Nocturia, urinary urgency ---- Result -- All symptoms gone. All patients, except one, benefited from the therapy. No patient experienced any side effects from the therapy. This contrasts sharply with conventional therapies, which have major risks, particularly impotence. No patient experienced any significant problems with the treatment. The earlier stage patients showed no evidence of cancer after the XYTOS treatment. The one failure was patient #3 whose disease had progressed to far prior to the XYTOS treatment. He experienced a major reduction in PSA levels, but this was overwhelmed by other medical problems. Patient #5 should have had surgery, but he refused.


XYTOS, working at the forefront of the "Science of Medicine," is a Bio-Medical Technology Company concentrating on the research, development, and introduction of Next Generation Medicine and Medical Procedures in the areas of Stem Cell Therapies, Tissue Engineering, Cellular Medicine, and Cancer.


Contact:
On behalf of the Board of Directors of: XYTOS INC.Tim Cook, CEO, 702-421-5206info@xytos.com
Get rich slow get poor fast.
“When a man with money meets a man with experience, the man with the experience ends up with the money, and the man with the money ends up with the experience.”
 
arizonagold  - posted
XYTS -

· Imagine a future where the fear of testing for cancer is eliminated by the use of a completely non-invasive procedure.
· Imagine the possibility of transforming cancer from the #1 killer of Americans under the age of 85, to a disease of the past.
· Imagine a future where cancer is detected as single cells, years before a detectable tumor.
· Imagine a future where a diagnosis of cancer is considered an inconvenience and not a life threatening disease.

What a great concept. This could be the one we have been looking for. IMO
 
luckylindy  - posted
XYTS NEWS: XYTOS Introduces Their Cancer Diagnostic Fluorescent Scanning Technique

ShareretweetEmailPrintCompanies:XYTOS INC Related Quotes
Symbol Price Change
XYTS.PK 0.38 +0.08


{"s" : "xyts.pk","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""} Press Release Source: XYTOS, Inc. On Friday January 28, 2011, 8:30 am EST

CARSON CITY, Nev.--(BUSINESS WIRE)-- XYTOS (the "Company") (OTC:XYTS.ob - News) is excited to announce their Cancer Diagnostic Fluorescent Scanning Technique.


The XYTOS procedure is a major achievement in the fight against cancer. XYTOS expects that their fluorescent scanning technique will soon become the standard for diagnosing Breast and Skin Cancer. XYTOS is able to illuminate cancer cells years before the cancer would be detectable by current diagnostic procedures such as the mammogram. This early diagnostic technique allows XYTOS to fight cancer at the very earliest stages, before a lump can develop. Fluorescent Scanning works best on Breast and Skin Cancer because the cancer is near the surface of the body. XYTOS Fluorescent Scanning has the ability to detect cancer at its earliest stages well before it becomes a tumor. At present, the mammogram is the accepted diagnostic tool for detecting breast cancer. From day one through 3 years cancer is undetectable using a mammogram. Cancer cells could possibly be present 3 years before they are detectable by a mammogram, and by the time the cancer is detected by mammogram in the form of a lump/tumor the cancer has been present for 6 plus years. In time XYTOS expects their fluorescent scanning technique to become the standard for diagnosing Breast and Skin Cancer.


Tim Cook, Chairman and CEO of XYTOS, Inc., commented, “We are truly excited about this new innovative and non-invasive cancer diagnostic technique for detecting surface and near surface cancerous tumors. After taking XyChloro® sublingually, XyChloro® will fluoresce at a specific wavelength as the body is scanned with a laser. Fluorescent radiation from XyChloro® activated inside the tumors is detected with a camera fitted with a filter and displayed on a TV screen or computer. Cancer shows up as fluorescent areas of various shapes and sizes. The fluorescence’s is in the form of a bright white spot under the skin. Pictures of how the cancer looks when scanned can be seen on our website at www.xytos.com. Additionally readers can cut and paste the following link to see a short video of a XYTOS patient undergoing Fluorescent Scanning Diagnostics (xytos.com/fsp.mov). Note that the patient is resting comfortably during the procedure. Further, although it takes a trained professional to interpret the full results of the procedure, the viewer will clearly see a bright white spot under the patient's left eye, which is cancerous. Finally it is important to understand that fluorescent scanning works best on surface and near surface cancers, namely breast and skin. With deeper tumors we must rely on more conventional diagnostic techniques at this time.”


XYTOS, working at the forefront of the "Science of Medicine," is a Bio-Medical Technology Company concentrating on the research, development, and introduction of Next Generation Medicine and Medical Procedures in the areas of Stem Cell Therapies, Tissue Engineering, Cellular Medicine, and Cancer.


Contact:
On behalf of the Board of Directors of: XYTOS INC.Tim Cook, CEO, 702-421-5206info@xytos.com
 
arizonagold  - posted
XYTS - Nothing strikes fear into a person than the word "CANCER". XYTOS INC. (XYTS) developers of fluorescent scanning technique that works wonders at discovering breast and skin cancer even before a lump developes. Non invasive and earlier detection. WoW! IMO
 
arizonagold  - posted
YXTS - Intraday chart looks good. People, companies who develope procedures that benefit us all should see great growth in their companies and in their stock. IMO
 



Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share